IP Library Assignment 029799/0771
Patent Assignment
Reel/Frame 029799/0771

Assignment of Assignor's Interest

Recorded: 2013-02-12 Pages: 4
Assignors
EMLEN, WOODRUFF
Executed: 2008-07-02
HOLERS, V. MICHAEL
Executed: 2008-07-02
FLYNN, PETER
Executed: 2008-06-18
Assignee
TALIGEN THERAPEUTICS, INC.
245 FIRST STREET, SUITE 1100, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property (1)
Humaneered Anti-Factor B Antibody
Patent: 9,096,677 →
Application: 13/722,071 →
Publication: US 2013/0216529
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Feb 12, 2013
From: TALIGEN THERAPEUTICS, INC.
To: ALEXION CAMBRIDGE CORPORATION
Reel/Frame 029799/0958 →
Change of Address Feb 12, 2013
From: ALEXION CAMBRIDGE CORPORATION
To: ALEXION CAMBRIDGE CORPORATION
Reel/Frame 029801/0586 →
Merger Jun 19, 2015
From: ALEXION CAMBRIDGE CORPORATION
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 035866/0477 →